Restrictive transfusion strategy after cardiac surgery.
Zeroual N, Blin C, Saour M, et al.
Anesthesiology 2021;134:370-380.
Review by H. B. Ravn
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
COVIDSurg Collaborative; GlobalSurg Collaborative
Anaesthesia 2022;77:28-39.
Review by C. M. Samama
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Baksaas-Aasen K, Gall LS, Stensballe J, et al.
Intensive Care Med 2021;47:49-59.
Review by D. Faraoni
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Richards T, Rao Baikady R, Clevenger B, et al.
Lancet 2020;396:1353-1361
Review by J. Meier
Routine venous thromboembolism prophylaxis may be inadequate in the hypercoagulable state of severe coronavirus disease 2019.
Maatman TK, Jalali F, Feizpour C, et al.
Crit Care Med 2020;48:e783-e790.
Review by C. M. Samama
Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH randomized clinical trial.
Futier E, Garot M, Godet T, et al.
JAMA 2020;323:225-236.
Review by J. Meier
Fibrinogen concentrate to cardiac surgery patients with ongoing bleeding does not increase the risk of thromboembolic complications or death.
Waldén K, Jeppsson A, Nasic S, Karlsson M
Thromb Haemost 2020;120:384-391.
Review by H. B. Ravn
Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials.
Wolf M, Rubin J, Achebe M, et al.
JAMA 2020;323:432-443.
Review by M. Auerbach
Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial.
Tay J, Allan DS, Chatelain E, et al.
J Clin Oncol 2020;38:1463-1473.
Review by M. T. Prochaska
Postoperative anaemia might be a risk factor for postoperative delirium and prolonged hospital stay: A secondary analysis of a prospective cohort study.
Kunz JV, Spies CD, Bichmann A, Sieg M, Mueller A
PLoS One 2020;15:e0229325.
Review by M. T. Prochaska
Improving preoperative haemoglobin using a quality improvement approach to treat iron deficiency anaemia.
Sinclair RC, Duffield KE, de Pennington JH
BMJ Open Qual 2020;9:e000776.
Review by J.-F. Hardy
NATA CME Webinar – Haemostatic monitoring and clinical decision making in patients with COVID–19-induced coagulopathy
The objective of this webinar is to provide participants with an update on the assessment and the management of coagulopathy associated with COVID–19. The live... Read More
Variation in red cell transfusion practice in the intensive care unit – An international survey.
Willems SA, Kranenburg FJ, Le Cessie S, et al.
J Crit Care 2020;55:140-144.
Review by S. Valentine
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male C, Lensing AWA, Palumbo JS, et al.
Lancet Haematol 2020;7:e18-e27.
Review by J. M. Cholette
Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death.
Fustolo-Gunnink SF, Fijnvandraat K, van Klaveren D, et al.
Blood 2019;134:2354-2360.
Review by J. M. Cholette
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659